PHEOCHROMOCYTOMA ASSOCIATED WITH PRIOR CAROTID-BODY TUMORS (CHEMODECTOMAS) - DETECTION WITH I-131 METAIODOBENZYLGUANIDINE

被引:3
|
作者
CAMPEAU, RJ
GRAVES, C
机构
[1] TULANE UNIV,MED CTR,DEPT INTERNAL MED,NEW ORLEANS,LA 70112
[2] NORTHSHORE REG MED CTR,DEPT INTERNAL MED,SLIDELL,LA
关键词
D O I
10.1097/00003072-199107000-00012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Chemodectomas (carotid body tumors) were surgically removed on two occasions, first 10 years and then 3 months prior to detection with I-131 MIBG of an adrenal pheochromocytoma in a 32-year-old man with a family history of chemodectoma. Recent reports suggest patients with multiple and/or familial instances of chemodectoma frequently have associated catecholamine-secreting tumors detectable with I-131 or I-123 MIBG. This case documents the above association and suggests that any patient with proven carotid body tumor(s) be screened for catecholamine-secreting tumors via urinary/plasma catecholamine determinations.
引用
收藏
页码:511 / 512
页数:2
相关论文
共 50 条
  • [21] PHEOCHROMOCYTOMA AND FUNCTIONING PARAGANGLIOMA IN CHILDHOOD AND ADOLESCENCE - ROLE OF I-131 METAIODOBENZYLGUANIDINE
    KHAFAGI, FA
    SHAPIRO, B
    FISCHER, M
    SISSON, JC
    HUTCHINSON, R
    BEIERWALTES, WH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1991, 18 (03): : 191 - 198
  • [22] COMPUTED-TOMOGRAPHY AND I-131 METAIODOBENZYLGUANIDINE SCINTIGRAPHY IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA
    KOIZUMI, M
    ENDO, K
    SAKAHARA, H
    NAKASHIMA, T
    NAKANO, Y
    NAKAO, K
    TORIZUKA, K
    ACTA RADIOLOGICA-DIAGNOSIS, 1986, 27 (03): : 305 - 309
  • [23] I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paraganglioma
    Zhang, Xue
    Wakabayashi, Hiroshi
    Kayano, Daiki
    Inaki, Anri
    Kinuya, Seigo
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (03): : 231 - 239
  • [24] RADIONUCLIDE DIAGNOSIS AND THERAPY OF NEURAL CREST TUMORS (NCT) WITH I-131 METAIODOBENZYLGUANIDINE (I-131-METAIODOBENZYLGUANIDINE)
    VOUTE, PA
    HOEFNAGEL, CA
    DEKRAKER, J
    MARCUSE, HR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 206 - 206
  • [25] ASSESSMENT OF THE AVIDITY OF NEUROADRENERGIC TUMORS FOR I-131 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) AND ITS SIGNIFICANCE IN METAIODOBENZYLGUANIDINE THERAPY
    HAPP, J
    GRIESE, J
    MANEGOLD, KH
    MAUL, FD
    BAUM, RP
    NITZ, C
    SCHWABE, D
    HOR, G
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 948 - 948
  • [26] I-131 METAIODOBENZYLGUANIDINE IN DIAGNOSIS AND THERAPY OF CARCINOID-TUMORS
    CASTELLANI, MR
    DIBARTOLOMEO, M
    MAFFIOLI, L
    ZILEMBO, N
    SEREGNI, E
    BURAGGI, GL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 708 - 708
  • [27] PRIMARY EXTRAADRENAL PHEOCHROMOCYTOMA POSITIVE I-123 METAIODOBENZYLGUANIDINE IMAGING WITH NEGATIVE I-131 METAIODOBENZYLGUANIDINE IMAGING
    SHULKIN, BL
    SHAPIRO, B
    FRANCIS, IR
    DORR, R
    SHEN, SW
    SISSON, JC
    CLINICAL NUCLEAR MEDICINE, 1986, 11 (12) : 851 - 854
  • [28] PHEOCHROMOCYTOMA AND PARAGANGLIOMA - COMPARISON OF MR IMAGING WITH CT AND I-131 METAIODOBENZYLGUANIDINE SCINTIGRAPHY
    QUINT, LE
    GLAZER, GM
    FRANCIS, IR
    SHAPIRO, B
    CHENEVERT, TL
    RADIOLOGY, 1987, 165 (01) : 89 - 93
  • [29] I-131 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) AND COMPUTED-TOMOGRAPHY (CT) IMAGING IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA (PHEO) STUDY
    ANSARI, AN
    SIEGEL, ME
    DEQUATTRO, V
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 929 - 929
  • [30] UNSUCCESSFUL I-131 METAIODOBENZYLGUANIDINE IMAGING OF CARCINOID-TUMORS AND APUDOMAS
    SINZINGER, H
    RENNER, F
    GRANEGGER, S
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (07) : 1221 - 1222